Chul Cho B, Han JY, Hyeong Lee K, Lee YG, et al. Lazertinib as a frontline treatment in patients with EGFR-mutated advanced non-small cell lung cancer: Long-term follow-up results from LASER201. Lung Cancer 2024;190:107509.
PMID: 38432025